- Home
- TVRD vs VUZI Comparison
TVRD vs VUZI Comparison
Compare TVRD & VUZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- VUZI
- Stock Information
- Founded
- TVRD 2017
- VUZI 1997
- Country
- TVRD United States
- VUZI United States
- Employees
- TVRD N/A
- VUZI N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- VUZI Industrial Machinery/Components
- Sector
- TVRD Health Care
- VUZI Technology
- Exchange
- TVRD Nasdaq
- VUZI Nasdaq
- Market Cap
- TVRD 246.5M
- VUZI 236.4M
- IPO Year
- TVRD N/A
- VUZI N/A
- Fundamental
- Price
- TVRD $25.77
- VUZI $2.86
- Analyst Decision
- TVRD Strong Buy
- VUZI Strong Buy
- Analyst Count
- TVRD 3
- VUZI 1
- Target Price
- TVRD $60.67
- VUZI $2.00
- AVG Volume (30 Days)
- TVRD 56.7K
- VUZI 2.0M
- Earning Date
- TVRD 05-13-2025
- VUZI 08-13-2025
- Dividend Yield
- TVRD N/A
- VUZI N/A
- EPS Growth
- TVRD N/A
- VUZI N/A
- EPS
- TVRD N/A
- VUZI N/A
- Revenue
- TVRD N/A
- VUZI $5,331,630.00
- Revenue This Year
- TVRD N/A
- VUZI $45.35
- Revenue Next Year
- TVRD N/A
- VUZI $54.01
- P/E Ratio
- TVRD N/A
- VUZI N/A
- Revenue Growth
- TVRD N/A
- VUZI N/A
- 52 Week Low
- TVRD $8.13
- VUZI $0.83
- 52 Week High
- TVRD $34.31
- VUZI $5.79
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- VUZI 53.39
- Support Level
- TVRD N/A
- VUZI $2.97
- Resistance Level
- TVRD N/A
- VUZI $3.29
- Average True Range (ATR)
- TVRD 0.00
- VUZI 0.21
- MACD
- TVRD 0.00
- VUZI -0.04
- Stochastic Oscillator
- TVRD 0.00
- VUZI 25.76
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.